Corporate governance report 2012 - Nobel Biocare Corporate

Corporate Governance report 77
10. Executive Committee
Richard T. Laube
Chief Executive Officer (CEO), dual Swiss-US citizen, born
1956. Richard T. Laube was appointed Chief Executive Officer
as of April 2011. Prior to joining Nobel Biocare, Richard Laube
held the position of CEO of Nestlé Nutrition, Nestlé SA and
was a member of the Nestlé Executive Board (2005–2010).
He had joined Nestlé as Deputy Executive Vice President, Corporate
Business Development in 2005. From 1999–2005 he
was President of Roche Consumer Health and from 2001–
2005 also Member of the Roche Corporate Executive Committee.
He also held the positions as Managing Director, Procter
& Gamble, Brazil (1996–1999), General Manager, Procter
& Gamble Pharmaceuticals, Germany (1992–1996) and
various marketing and brand management positions with
Procter & Gamble in Japan, the US, and Switzerland (1980–
1992). Education: Master and Bachelor degrees in Organizational
Development and Evaluation Research, Boston University.
Current other assignments: Since 2008 Independent
Director of Logitech SA and member of its Compensation
Committee. Since 2010 he is Executive Advisor of Roark
Capital Group. Shares: 110’000 / Performance share units:
32’573 / Staff options: 0.
Dirk W. Kirsten
Chief Financial Officer (CFO), Swiss-German dual citizen,
born 1968. Dirk W. Kirsten was appointed Chief Financial
Officer of Nobel Biocare, effective March 2008. He brings to
Nobel Biocare extensive financial expertise, gained over
14 years in various finance and senior finance positions on
the banking, corporate and advisory side. Prior to joining
Nobel Biocare, Dirk Kirsten held the position of Group Treasurer
at Syngenta (agribusiness, 2005–2008) in Basel, Switzerland.
Before Syngenta, he was a senior finance executive
at Roche Holding AG, in Basel (healthcare, 2002–2004). Prior
to his corporate experience, Dirk Kirsten worked with Deutsche
Bank (2000–2002), PricewaterhouseCoopers (assurance,
tax and legal advisory services, 1999–2000) and UBS
(1995–1998; formerly: SBC Warburg) in various international
advisory and investment banking positions. Education: PhD
in Management with specialization in Corporate Finance/Shareholder
Value Management, University of Cologne, Germany;
MBA Class, London Business School, London, England
(Program of International Management), in combination
with Master Studies (Business administration: Finance, Tax,
Accounting) at University of Cologne, Germany. Current other
assignments: No other relevant current assignments. Shares:
2’600 / Performance share units: 45’254 / Staff options: 0.
Hans Geiselhöringer
Executive Vice President Global Research Products &
Development*, German, born 1968. Hans Geiselhöringer
was appointed Executive Vice President Global Marketing &
Products in 2010. He joined Nobel Biocare in 2008 to lead the
company’s NobelProcera business. Prior to joining Nobel Biocare,
he had been expanding his Dental X laboratory business
internationally. Hans Geiselhöringer founded Dental X GmbH
in 1998, a dental laboratory chain specializing in implantology,
anaplastology, functional and esthetic reconstructions, and
imaging technologies. Education: Trained as a Certified Dental
Technician (CDT) in Chicago, USA; further dental training
in New York, focusing on anaplastology and epithetics; Technical
business administrator from the German Chamber of
Commerce and Industry (IHK). Current other assignments:
No other relevant current assignments. Shares: 0 / Performance
share units: 28’500 / Staff options: 0.
* Under management service contract until 31 December 2011
Melker Nilsson
Executive Vice President Global Customer and Sales
Development, Swedish citizen, born 1960. Melker Nilsson
was appointed Executive Vice President Global Customer and
Sales Development in August 2011. Previously he held the
position as President and General Manager North America
(January-August 2011) and Chief Operating Officer North
America for Nobel Biocare (2010-2011). From 2006-2009 he
was President of Neoss US (dental implants, 2006-2009).
Prior to that, Melker Nilsson held various management
assignments at Nobel Biocare in Europe and North America
from 1992-2005 and various management positions in sales
and marketing in Luxembourg, Germany and Sweden for
Nordea (banking, 1986-1991). Education: Master’s degree in
law from Lund University in Sweden. Shares: 0 / Performance
share units: 12,512 /Staff options: 0.
Petra Rumpf
Senior Vice President, Business Development and Strategic
Planning, German, born 1967. Petra Rumpf joined Nobel
Biocare in December 2007 as Vice President Business Development
and Strategic Planning. Previously, she spent
16 years with Capgemini Transformation Consulting gaining
experience in strategy development, business transformation,
and mergers and acquisitions working with leading corporations
in life sciences, manufacturing and high-tech industries.
From 2002 until 2007, she was Vice President and